Chronic Cerebral Ischemia: From Pathogenesis to Therapy (Recommendations for an Outpatient Neurologist)
Keywords:
cerebrovascular disease, cerebral microangiopathy, arterial hypertension, endothelial dysfunction, symptoms, DivasaAbstract
The prevalence of cerebrovascular disease is increasing, significantly affecting patients' quality of life and often leading to disability. Disorders of small-caliber cerebral vessels contribute to nearly 40% of dementia cases worldwide and account for one in every five strokes occurring each year. Cerebral microangiopathy can also cause structural damage to the brain, including white matter lesions, lacunar infarcts, microbleeds, and secondary cerebral atrophy. These changes may remain unnoticed for years but greatly increase the risk of dementia and disabling strokes.
Arterial hypertension is the most common cause of cerebral microangiopathy, leading to arteriosclerosis in small penetrating arteries and arterioles. Endothelial dysfunction plays a crucial role in initiating and sustaining vascular damage. Research shows that individuals with cerebral microangiopathy have elevated markers of endothelial injury in their blood. Early and effective therapy is essential in reversing endothelial dysfunction and preventing cerebrovascular disease.
Divaza, a pleiotropic drug, has been scientifically proven to be an effective adjuvant therapy for managing anxiety and depressive symptoms associated with cerebral microangiopathy.
References
E. . Tashkenbaeva и others, «PREVALENCE OF METABOLIC SYNDROME IN PATIENTS WITH CORONARY HEART DISEASE», J. Cardiorespir. Res., т. 2, вып. 1, сс. 85–88, 2021.
G. T. Madjidova, G. I. Sunnatova, и S. A. Usarov, «ABOUT THE SYSTEM OF TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME», Eurasian J. Med. Nat. Sci., т. 2, вып. 5, сс. 197–204, 2022.
S. N. Alisherovna и others, «CLINICAL AND DIAGNOSTIC FEATURES OF MYOCARDIAL INFARCTION IN YOUNG PATIENTS IN EMERGENCY MEDICINE», Web Sci. Int. Sci. Res. J., т. 2, вып. 4, сс. 414–418, 2021.
N. A. Samadova и others, «Clinical and Diagnostic Features of Myocardial Infarction in Young Patients in Emergency Medicine», E-Conf. Globe, сс. 16–19, 2021.
G. T. Madjidova, G. I. Sunnatova, и N. S. Hamidov, «CLINICAL AND HEMODYNAMIC CONDITIONS AND HEART NATRIURETIC PEPTIDES IN THE BLOOD PLASMA OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY», Eurasian J. Med. Nat. Sci., т. 2, вып. 5, сс. 211–219, 2022.
S. N. Alisherovna и others, «Course of Myocardial Infarction in Young Women», Eurasian Med. Res. Period., т. 7, сс. 106–111, 2022.
Б. Тогаева и others, «COVID-19 YURAK QON TOMIR KASALLIKLARI BOR BEMORLARDA KECHISHI», Журнал Кардиореспираторных Исследований, т. 2, вып. 2, сс. 47–50, 2021.
F. O. Khasanjanova и others, «Evaluation of the effectiveness of thrombolytic therapy in men with acute coronary myocardial infarction in young age», Cent. Asian J. Med. Nat. Sci., т. 2, вып. 1, сс. 144–149, 2021.
F. O. Khasanzhanova и others, «EVALUATION OF THE EFFECTIVENESS OF THROMBOLYTIC THERAPY IN MEN WITH ACUTE MYOCARDIAL INFARCTION IN YOUNG AGE», Arch. Conf., т. 15, вып. 1, сс. 48–52, 2021.
S. N. Alisherovna и others, «FEATURES OF THE CLINICAL COURSE OF UNSTABLE ANGINA ON THE BACKGROUND OF COPD», Web Sci. Int. Sci. Res. J., т. 3, вып. 5, сс. 82–86, 2022.
Н. Самадова и others, «SHOSHILINCH TIBBIY YORDAMDA YOSH BEMORLARDA MIOKARD INFARKTINING KLINIK VA DIAGNOSTIK XUSUSIYATLARI», Журнал Кардиореспираторных Исследований, т. 2, вып. 1, сс. 78–81, 2021.
Tashkenbaeva, «Tashkenbaeva et al., “PREVALENCE OF METABOLIC SYNDROME IN PATIENTS WITH CORONARY HEART DISEASE,” Journal of Cardiorespiratory Research, vol. 2, iss. 1, pp. 85–88, 2021.»
K. F. Odilovna, S. N. Alisherovna, и B. S. Dilshodovna, «The role of the il-1b 3953 c/t gene in the development of unstable angina variants in young age men in the conditions of emergency medical care», 2022.
